当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:134.50亿  总市值:134.50亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,507,857,434.481,795,275,069.67940,368,885.052,741,264,907.1
  收到的税费返还50,749.8851,130.7420,438.86263,067.93
  收到其他与经营活动有关的现金50,292,275.8844,247,489.713,667,503.4936,111,466.43
  经营活动现金流入小计2,558,200,460.241,839,573,690.11954,056,827.42,777,639,441.46
  购买商品、接受劳务支付的现金821,382,359.36596,515,187.7320,428,057.22801,482,128.47
  支付给职工以及为职工支付的现金195,852,784.32131,348,731.7569,571,611.7233,357,322.12
  支付的各项税费195,300,610.67147,798,515.6666,211,607.23257,263,281.62
  支付其他与经营活动有关的现金1,186,791,466.36784,381,420.61525,433,112.521,185,009,850.91
  经营活动现金流出的平衡项目000-0.01
  经营活动现金流出小计2,399,327,220.711,660,043,855.72981,644,388.672,477,112,583.11
  经营活动产生的现金流量净额158,873,239.53179,529,834.39-27,587,561.27300,526,858.35
二、投资活动产生的现金流量:
  收回投资收到的现金105,000,000105,000,00045,739,075.35833,237,428.65
  取得投资收益收到的现金2,884,389.432,862,510.371,063,408.689,346,601.76
  处置固定资产、无形资产和其他长期资产收回的现金净额---4,082
  处置子公司及其他营业单位收到的现金净额---3,202,758.55
  收到的其他与投资活动有关的现金49,467,84049,467,84049,527,540554,329,379.17
  投资活动现金流入小计157,352,229.43157,330,350.3796,330,024.031,400,120,250.13
  购建固定资产、无形资产和其他长期资产支付的现金177,169,465.9120,365,414.7869,236,457.12316,374,344.31
  投资支付的现金147,130,000115,000,00055,000,000595,000,000
  支付其他与投资活动有关的现金---56,554,305.56
  投资活动现金流出小计324,299,465.9235,365,414.78124,236,457.12967,928,649.87
  投资活动产生的现金流量净额平衡项目0000.01
  投资活动产生的现金流量净额-166,947,236.47-78,035,064.41-27,906,433.09432,191,600.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金---2,000,000
  其中:子公司吸收少数股东投资收到的现金---2,000,000
  取得借款收到的现金---150,000,000
  收到其他与筹资活动有关的现金440,309,091.9415,388,536.34-634,676,783.33
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计440,309,091.9415,388,536.34-786,676,783.33
  偿还债务支付的现金150,000,000150,000,000150,000,000248,000,000
  分配股利、利润或偿付利息支付的现金200,672,175.8200,666,388.19135,416.67314,441,664.99
  其中:子公司支付给少数股东的股利、利润---1,286,387.22
  支付其他与筹资活动有关的现金472,434,628.5421,884,336.311,497,919.56417,384,135.29
  筹资活动现金流出小计823,106,804.3772,550,724.5151,633,336.23979,825,800.28
  筹资活动产生的现金流量净额-382,797,712.4-357,162,188.16-151,633,336.23-193,149,016.95
四、汇率变动对现金及现金等价物的影响25,235.78124,244.9820,332.55-48,386.26
  现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额-390,846,473.56-255,543,173.2-207,106,998.04539,521,055.4
  加:期初现金及现金等价物余额1,579,060,009.941,579,060,009.941,579,060,009.941,039,538,954.54
  期末现金及现金等价物余额1,188,213,536.381,323,516,836.741,371,953,011.91,579,060,009.94
补充资料:
  净利润-174,712,447.04-342,363,890.32
  资产减值准备-1,349,645.31-12,233,506.16
  固定资产和投资性房地产折旧-15,816,105.8-20,518,008.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,816,105.8-20,518,008.83
  无形资产摊销-1,866,733.84-4,073,362.03
  长期待摊费用摊销-6,412,402.73-1,433,270.35
  处置固定资产、无形资产和其他长期资产的损失--377,398.06--29,631.89
  固定资产报废损失-39,562.75-314,782.26
  公允价值变动损失--587,598.74-982,898.54
  财务费用-2,656,560.66-9,901,066.66
  投资损失--2,783,249.38--20,024,755.1
  递延所得税-4,347,474.62--35,707,131.13
  其中:递延所得税资产减少-5,872,785.95--32,741,819.61
    递延所得税负债增加--1,525,311.33--2,965,311.52
  存货的减少--22,795,755.2--60,163,685.74
  经营性应收项目的减少-21,324,624.09--41,383,998.97
  经营性应付项目的增加--22,390,834.6-61,914,325.91
  其他--428,994.71-542,711.25
  现金的期末余额-1,323,516,836.74-1,579,060,009.94
  减:现金的期初余额-1,579,060,009.94-1,039,538,954.54
  现金及现金等价物的净增加额--255,543,173.2-539,521,055.4
公告日期2025-10-312025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑